Microbiology & Infectious Diseases

A new report from the UK Health Security Agency (UKHSA) highlights profound inequalities in infectious disease outcomes and hospital admissions across England.

Clinically, this discovery could reshape the understanding of immune regulation in ulcerative colitis.

Ceftazidime/avibactam, a key antimicrobial against multidrug-resistant Gram-negative pathogens, has seen increasing use across England since its 2017 launch.

Discover a study where researchers administered appetite-related hormones leptin and ghrelin directly into the brain.

In this study, modelling predicts millions of cases of measle if vaccination rates continue to fall.

Shorter, all-oral bedaquiline-based regimens show 83% success in drug-resistant TB, cutting risk of death and failure.

A large-scale study has identified key predictors of Oropouche virus transmission risk across Latin America, providing insights into the 2023–24 outbreak.

The WHO has released its updated 2024 Bacterial Priority Pathogens List, offering clinicians and researchers a more granular framework for guiding antimicrobial stewardship.